Navigation Links
Isis Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
Date:3/17/2010

ams are focused on treating cardiovascular, metabolic, and severe neurodegenerative diseases and cancer.  Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases.  Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics.  Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing.  As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide.  Additional information about Isis is available at www.isispharm.com.

SOURCE Isis Pharmaceuticals, Inc.

Back to top

RELATED LINKS
http://www.isispharm.com

'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 Research and ... of the "Market Assessment of Respiratory Diagnostics ... to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This ... imaging diagnostics market in the United ... . The service provides detailed analysis of the ...
(Date:5/21/2015)... 21, 2015  Cardica, Inc. (Nasdaq: CRDC ) today ... Watson , the company,s vice president of operations, was granted ... stock, at a per share exercise price of $0.43, the ... was granted pursuant to Cardica, Inc.,s Inducement Plan, which was ... under Rule 5653(c)(4) of the Nasdaq Global Market for equity ...
(Date:5/21/2015)... YORK , 21. Mai 2015 ... DPRX ), ein Unternehmen für ... auf die Entwicklung und Vermarktung von ... konzentriert, kündigte heute eine wissenschaftliche Posterpräsentation ... Phase-III-Zulassungsstudie des Unternehmens vorstellt, OneStep-1 und ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2Cardica Announces New Employment Inducement Grant 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... DIEGO, May 19 DDW 2008 Annual Meeting ... its pivotal trial,demonstrated physician/nurse teams using the SEDASYS(TM) ... in patients undergoing screening and,diagnostic procedures for colorectal ... (EGD). The study -- which will be,presented Tuesday ...
... Replacement Structurally Similar to, Native Bladder by Six Months; Data Presented ... ... Poster Session, ORLANDO, Fla. and EAST NORRITON, Pa., May ... development of,neo-organs and neo-vessels, presented preclinical efficacy data for its,Tengion Neo-Bladder ...
Cached Medicine Technology:Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 2Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 3Pivotal Study Shows Physician/Nurse Teams Using SEDASYS(TM) System Reduced Risk of Over Sedation With Propofol 4Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM) 2
(Date:5/24/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... many patients for concerns about hair loss. Although it ... is clear that there are environmental factors such as ... that can contribute. Since they offer a comprehensive approach ... the peri and post-menopausal woman, they can help patients ...
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific consulting firm, ... that may have raised the risk of mesothelioma for ... an article on the research. Click here to ... asbestos levels well above OSHA safety guidelines when they ... “Asbestos compliance sampling data associated with the construction, automotive ...
(Date:5/24/2015)... 24, 2015 ProPin is a set ... Pro X. Utilize ProPin to pin point locations on a ... , ProPin allows users to choose from 30 simplistic ... With on-screen controls, video editors can easily manipulate ProPin presets ... and mark with absolute ease. , Using ProPin is easy, simply ...
(Date:5/24/2015)... 24, 2015 ... - The students were selected ... the fourth annual A Day of ... Geneva National in Lake Geneva. , ... High School,         Jonathan Alfonso,         Bridget Keefe, ...
(Date:5/23/2015)... May 23, 2015 On May 13, ... of a youngster's yogic power learned through meditation and ... Swami in Bangalore, India. , Yogamaatha, a nine-year-old girl ... 50 high profile professionals attending the 2015 Business Advocacy ... fluently -- blindfolded. , In a demonstration that ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3
... MONDAY, Feb. 21 (HealthDay News) -- Seniors who are more ... The study from Rush University in Chicago looked at ... of disability at the start of the study period. The ... about their social activities, such as going out to eat, ...
... cancer diagnosis is a devastating experience. Still under the shock ... who to turn to for advice and treatment, with the ... hospital or a community oncology hospital. "When my ... the diagnosis (Plasmocytoma), I was disoriented. As a patient I ...
... New research shows people who have used amphetamines such ... increased risk of developing Parkinson,s disease, according to a ... American Academy of Neurology,s 63rd Annual Meeting in Honolulu ... and Dexedrine are amphetamines often prescribed to increase wakefulness ...
... with yourself, gain an extra limb or change into a ... that the brain,s image of the body is negotiable. Applications ... Ask a child if their hands belong to them ... brain actually identify its own body? And why do we ...
... researchers generally credit the desire for smaller families for the ... suggests that prevention of unwanted births may actually be a ... birth control means that people have better control of when ... the Initiative in Population Research at Ohio State University. ...
... This release is available in French . ... Ecosystems and Society at the University of Northern British Columbia, ... "My research focuses on the relationships between ecosystems ... THINK CANADA Press Breakfast panel discussion today at AAAS. Originally ...
Cached Medicine News:Health News:Busy Social Life May Stave Off Disability in Elderly 2Health News:Community oncology: Ensuring the best standards of care 2Health News:Community oncology: Ensuring the best standards of care 3Health News:Community oncology: Ensuring the best standards of care 4Health News:Using amphetamines may increase risk of Parkinson's disease 2Health News:How to leave your body 2Health News:Family planning programs have success in developing countries, but need to be expanded 2Health News:Family planning programs have success in developing countries, but need to be expanded 3Health News:How we manage water resources has a direct impact on our health, says Canada Research Chair 2
... TruFlow™ Oxygen flowmeter with a Lexan®inner calibrated ... calibration and manufacturing defects. A wide range ... needs. Also available with all popular inlet ... and double unit configurations. Our extra large ...
... with a Lexan®inner calibrated flow tube has ... defects. A wide range of configurations are ... with all popular inlet connections, a 50 ... configurations. Our extra large knob coupled with ...
... series of time-tested Timeter® Classic Flowmeters demonstrates ... care providers and patients alike. You can ... see it in the craftsmanship. You can ... year. Every Timeter® Classic Flowmeter is hand-crafted ...
... series of time-tested Timeter® Classic Flowmeters demonstrates ... care providers and patients alike. You can ... see it in the craftsmanship. You can ... year. Every Timeter® Classic Flowmeter is hand-crafted ...
Medicine Products: